Quantbot Technologies’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-964
Closed -$21.4K 1667
2023
Q4
$21.4K Sell
964
-1,116
-54% -$16.8K ﹤0.01% 1425
2023
Q3
$44.9K Buy
+2,080
New +$81.7K ﹤0.01% 1266
2023
Q2
Sell
-680
Closed -$317K 1688
2023
Q1
$317K Buy
+680
New +$360K 0.02% 752
2022
Q3
Sell
-150
Closed -$39K 1735
2022
Q2
$39K Buy
+150
New +$38.3K ﹤0.01% 1343
2021
Q4
Sell
-532
Closed -$135K 1649
2021
Q3
$135K Buy
+532
New +$189K 0.01% 898
2021
Q2
Sell
-267
Closed -$232K 1568
2021
Q1
$232K Buy
+267
New +$284K 0.02% 682
2020
Q4
Sell
-119
Closed -$121K 1409
2020
Q3
$121K Buy
119
+48
+68% +$51.6K 0.01% 687
2020
Q2
$72K Buy
+71
New +$65.9K 0.01% 644
2020
Q1
Sell
-132
Closed -$141K 1055
2019
Q4
$141K Buy
132
+75
+132% +$76.6K 0.01% 743
2019
Q3
$52K Buy
+57
New +$62.6K 0.01% 958
2018
Q4
Sell
-31
Closed -$46K 1137
2018
Q3
$46K Sell
31
-16
-34% -$24.6K ﹤0.01% 1055
2018
Q2
$74K Buy
+47
New +$61.3K 0.01% 927
2017
Q4
Sell
-1
Closed -$1K 1283
2017
Q3
$1K Sell
1
-158
-99% -$166K ﹤0.01% 1129
2017
Q2
$128K Buy
+159
New +$111K 0.01% 752
2016
Q4
Sell
-203
Closed -$104K 1139
2016
Q3
$104K Sell
203
-197
-49% -$92.8K 0.01% 719
2016
Q2
$164K Buy
+400
New +$183K 0.02% 611

Other funds holding KYNB

Quantbot Technologies's KYNB Position: Q1 2024 in Review

Quantbot Technologies sold out of Kyntra Bio (KYNB) in Q1 2024, closing a stake of 964 shares — an estimated $21.4K sold.

Quantbot Technologies first reported a position in KYNB in Q2 2016 and held it in 16 quarters. The position peaked at $317K in Q1 2023. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • Quantbot Technologies reported no remaining Kyntra Bio position as of Q1 2024 after selling out during the quarter.
  • Quantbot Technologies sold 964 Kyntra Bio shares in Q1 2024, an estimated $21.4K.
  • Quantbot Technologies first reported a position in Kyntra Bio in Q2 2016 and held it in 16 quarters.
  • Quantbot Technologies's Kyntra Bio position peaked at $317K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.